L
Lineage Cell Therapeutics, Inc. (LCTX)
ASE – Real Time Price. Currency in USD
1.28
+0.06 (4.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.28
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
1.28
+0.06 (4.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.28
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:41 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $35.9M significantly exceed its total debt $2.4M, ensuring strong financial flexibility
Total current assets $56.2M exceed Total current liabilities $8.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$8.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.89 | 6.05 | 10 | |
| Quick ratio | 6.89 | 5.63 | 10 | |
| Debt to Equity | 0.04 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 15M | 9M | 9M | 15M | 15M |
| Gross Profit | 13M | 8M | 9M | 14M | 14M |
| Operating Income | -23M | -25M | -21M | -22M | -23M |
| Net Income | -26M | -21M | -19M | -64M | -64M |
| EBITDA | -22M | -24M | -21M | -21M | -22M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 75.12 | 84.62 | 10 |
| Next quarter | -30.62 | 79.49 | 5.5 |
| Current year | 9.42 | 75.51 | 8.0 |
| Next year | -35.01 | -33.33 | 1.0 |
| Weighted average score | 6.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -73.89 | -665.44 | -849.99 | -54.11 | 1.0 |
| Y/Y | 14.85 | -16.25 | -49.99 | -63.2 | 2.8 |
| 3y average | 6.76 | -69.92 | -55.36 | -1529.79 | 2.0 |
| 5y average | 140.34 | -55.83 | -41.89 | -901.46 | 3.3 |
| Weighted average score | 2.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |